PCSK9 inhibition: Not just LDL-Cholesterol knock down: A glimmer for cancer

Comment on “Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer” which was published in Nature, doi:10.1038/s41586-020-2911-7.
Source: European Heart Journal - Category: Cardiology Source Type: research